The Metabolomics Innovation Centre (TMIC) is a nationally-funded core facility that has a unique combination of infrastructure and personnel to perform a wide range of cutting-edge metabolomic studies for clinical trials research, biomedical studies, bioproducts studies, nutrient profiling and environmental testing.
The platform is led by Dr. David Wishart (University of Alberta), Dr. Christoph Borchers (Universities of Victoria and McGill), Dr. Liang Li (University of Alberta), Dr. James Harynuk (University of Alberta), Dr. Michael Overduin (University of Alberta), and Dr. Philip Britz-McKibbin (McMaster University).
TMIC has access to more than $26 million in state-of-the-art metabolomics infrastructure. It is supported by a team of lab managers, NMR spectroscopists, mass spectrometrists, chemists, computer scientists, statisticians and bioinformaticians. TMIC is capable of identifying and quantifying up to 2000 different chemicals from certain biological samples. This is approximately 5X more comprehensive than any other service currently available.
We request that any publications, posters, or oral presentations resulting from work performed by The Metabolomics Innovation Centre acknowledge TMIC. This allows the Centre to report information to our funding agencies, such as impact on Canadian researchers. Clients should also keep us apprised of any publications, posters, or oral presentations arising from work performed at TMIC.